Profile
Scott M.
Plesha is currently Chief Executive Officer at LNHC, Inc. since 2023 and President, Chief Executive Officer & Director at Pelthos Therapeutics, Inc. starting in 2025.
Formerly, Mr. Plesha was Sales Manager-OClassen Dermatologics Division at Actavis, Inc. from 1998 to 2000, Senior Vice President-Sales Force & Training at Salix Pharmaceuticals Ltd. from 2011 to 2015, and President & Chief Commercial Officer at BioDelivery Sciences International, Inc. from 2018 to 2022.
Mr. Plesha completed undergraduate education at DePauw University.
Scott M. Plesha active positions
| Companies | Position | Start |
|---|
Former positions of Scott M. Plesha
| Companies | Position | End |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | President | 2022-03-21 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 2015-03-31 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Sales & Marketing | 2000-08-31 |
Training of Scott M. Plesha
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Scott M. Plesha
















